Version Française
NEWS RSS
19/06/2013
Partnership in Clinical Trials - Russia-CIS/MENA-Turkey - 22-23 May 2013 - Istanbul

TWO conferences with ONE shared exhibition space to maximise networking opportunities with attendees.

19/06/2013
Belgian Trade mission presided by HRH Prince Philippe, June 2 to 9, 2013 - California Los Angeles/San Diego/San Francisco

Keyrus Biopharma Delegation will participate to this important Belgian Trade mission with the objectives to develop our collaboration with US Biotech [...]

Feasability and
project management
Regulatory Affairs
Data Management
Clinical Trials
Biostatistics
Medical Writing
Pharmacovigilance
Bioinformatics
Contact us
About Us

Relationship with the Keyrus Group

Keyrus Biopharma belongs to the Keyrus group founded in 1996.

International player in Consultancy and integration of Business Intelligence and e-business solutions for major companies and ERP/CRM solutions for the Mid-Market,  Keyrus has 1650 employees located in 12 countries and assists its clients in performance optimisation by offering a complete set of services in the following fields:

  • Consulting Management
  • Business Intelligence- Performance Management
  • e-Business - Performance Web
  • Management Solutions for the company ( ERP/CRM)

The Keyrus Group is part of the  Eurolist by Euronext Paris ( Compartiment C/Small caps -Code ISIN : FR0004029411 – Reuters : KEYR.LN – Bloomberg : KEYP FP)

More information on www.keyrus.com

A working relationship has been developed between Keyrus and Keyrus Biopharma, combining Keyrus’ expertise in the field of information systems development and database integration with the pharmaceutical know-how of Keyrus Biopharma.

As such, Keyrus Biopharma proposes efficient solutions for our clients’ specific requirements, providing them with effective and adequate tools to perform clinical research.

  • Reporting in Pharmacovigilance and Clinical Research with Business Objects
  • Consultancy in Health Economics (PMSI data)
  • Marketing services (statistics, prediction, symbolic data)
  • Building of key indicators for clinical trial steering